Specific Clinical Experience Investigation for long-term use of Bydureon subcutaneous injection 2 mg and Bydureon SC Pen 2 mg (PMS Bydureon Long Term Use SCEI)

18/04/2017
14/03/2024
EU PAS number:
EUPAS18608
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

D5551C00001_BD_11-Dec-2014_ProtocolRedacted

English (117.52 KB - PDF) View document
Study results
Study results

D5551C00001_redacted_CSR_Synopsis

English (152.01 KB - PDF) View document
Study report
Other information